A murine respiratory infection model was used to study the mechanism of protective immunity to BordeteUla pertussis. We found that nude mice, which are deficient in T cells, developed a persistent infection and failed to clear the bacteria after aerosol inoculation. 
Bordetella pertussis is a gram-negative bacterium that causes whooping cough, a respiratory disease responsible for high levels of morbidity and mortality in children worldwide. Although the organism colonizes by attachment to ciliated respiratory epithelial cells and is considered to be noninvasive (3, 41, 61) , a number of recent reports have suggested that it can be taken up by and survive within mammalian cells, including macrophages (11, 16, 28, 48) .
After recovery from a nonlethal pertussis infection, immunity that provides long-lasting protection against subsequent disease develops (29) . Immunization with the whole-cell vaccine also confers a high level of immunity and has been successful in controlling the disease in most developed countries (20, 58) . However, the reactogenicity of this vaccine has motivated the search for a safer and more effective acellular pertussis vaccine (30, 43) . In a recent clinical trial in Sweden, an acellular vaccine comprising chemically detoxified pertussis toxin (PT) and filamentous hemagglutinin (FHA) was found to be capable of reducing the incidence of disease, but it was less effective than whole-cell vaccines (2) . Furthermore, the results of this trial failed to demonstrate a correlation between serum antibody responses to FHA or PT and protection.
Passive immunization experiments in mice have demonstrated that antibodies to several pertussis components can induce various degrees of protection against intracerebral or respiratory challenge (25, 38, 43, 46, 47) . Active immunization of mice with whole-cell and acellular pertussis vaccines has been shown to induce pertussis-specific serum antibodies and protection (10, 25, 38, 43, 47) . However, in a minority of studies, such as those in which mice were immunized with the PT B oligomer (53) , pertactin (52) , or an attenuated B. pertussis aroA mutant (42) , the antibody levels in serum were low or undetectable at the time of challenge but increased rapidly thereafter. Although these results are consistent with a protective role for circulating antibody transfusing into the lung after immunization or as a result of an amnestic antibody response soon after challenge, they do not rule out a contribution for local or cellular immune responses. A study that failed to find a correlation between serum antibodies and bacterial clearance after immunization of rabbits with FHA, outer membrane protein, or a wholecell vaccine suggested that protection correlated with levels of pertussis-specific immunoglobulin A (IgA) in the lungs (4) .
Indirect evidence for the role of T cells in immunity to pertussis is provided from reports that B. pertussis-specific T cells have been demonstrated in humans rendered immune after immunization or infection (15, 39, 40) . Furthermore, a number of cases of pertussis have been documented in patients with AIDS, a disease characterized by a depletion of CD4+ T cells (1, 8) . B. pertussis organisms were found inside pulmonary alveolar macrophages from these patients (8) , and it has been suggested that intracellular survival of B. pertussis is a mechanism for persistence within the respiratory tract (8, 28, 48) .
In studies of immunity to a variety of other infectious diseases, CD8+ and CD4+ T cells and subpopulations thereof have been shown to play a critical role (31) . The characteristics of the disease, particularly the site of pathogen replication, determines the relative contributions of distinct T-cell subsets. Cloned murine CD4+ T cells have been divided into two populations on the basis of functionphagocytic function of macrophages and neutrophils (26, 35, 50, 56) . In addition, Thl cells and CD8+ T cells are capable of killing cells infected with viruses, protozoan parasites, or intracellular bacteria such as listeriae and mycobacteria (23, 24, 31, 37, 59 ). Th2 helper CD4+ T cells secrete IL-4, IL-5, and IL-6 and are considered to be the predominant population responsible for providing the helper function for antibody responses to foreign antigens (7, 13, 35) . Consequently, CD4+ Thl and CD8+ T cells are thought to be involved in protection against intracellular pathogens through direct cell-mediated immunity, whereas CD4+ Th2 cells mediate protection against extracellular pathogens through the stimulation of humoral immunity (7, 35) .
In this study we used a murine respiratory infection model to examine the role of T cells in immunity to pertussis. Although this is not an ideal model, the pattern of infection induced by aerosol challenge has several of the characteristics of that seen in infected children and is considered by many to be the most practicable and relevant animal model for studies of pathogenesis and immunity to pertussis (41, 45, 55) . We reported previously that respiratory infection of adult mice generates strong proliferative T-cell responses against a number of pertussis antigens, including FHA, PT, a 69-kDa outer membrane protein (pertactin), and agglutinogens 2 and 3 (32) . In this report we demonstrate that B. pertussis-specific T cells induced by infection in mice are largely confined to the CD4+ T-cell subpopulation that secretes IL-2 and IFN--y and that these cells play a critical role in the clearance of bacteria after a primary infection and in the development of protective immunity against subsequent challenge.
MATERIALS AND METHODS
Mice. BALB/c (H-2d), CBA (H-2k), and NIH (H-2q) mice were bred and maintained under specific-pathogen-free conditions. NIH Preparation of spleen cell subpopulations. Spleens were removed, and a single-cell suspension was prepared in RPMI 1640 medium supplemented with 10% fetal calf serum (RiO medium). Dead cells, erythrocytes, and granulocytes were removed by centrifugation at 400 x g for 20 min at 20°C on an 18% metrizamide gradient prepared by diluting a 35% metrizamide (Nycomed) stock solution in H20 with RIO medium. The viable mononuclear cells at the interface of the gradient were removed and washed twice in R10 medium. A macrophage-and B-cell-depleted (T-cell-enriched) cell population was prepared from the mononuclear spleen cells by panning on anti-mouse Ig-coated plates prepared by overnight incubation of 90-mm petri dishes with 5 ml of a solution containing 25 ,ug of affinity-purified sheep anti-mouse Ig (polyvalent; Nordic Laboratories) per ml in PBS at 4°C. After four washes with PBS and two washes with R10 medium, 5 ml of the cell suspension (5 x 106/ml) was added.
The cells were incubated at room temperature for 70 min, and then the nonadherent cells were separated from the dishes and washed gently with 5-ml aliquots of R10 medium. The cells were centrifuged and resuspended at 5 x 106/ml, and the procedure was repeated on fresh Ig-coated plates except that the plates were incubated at 37°C. The depletion technique generated a cell population consisting of approximately 80% T cells and 2 to 5% contaminating B cells. T-cell-enriched fractions were also prepared by passage through a nylon-wool column followed by panning of the nonadherent cells on Ig-coated plates. This method generated a population that was 98% T cells with less than 1% B cells.
Thy-1+ cells were depleted from mononuclear spleen cell preparations by incubation at 107/ml for 30 min at 4°C with 1/1,000 dilution of anti-Thy-1 ascites fluid. After the cells were washed once in serum-free medium, they were resuspended in guinea pig serum diluted 1/10 in PBS as a source of complement and incubated at 37°C for 30 min. The T-cell proliferation and lymphokine assays. Spleen cells from aerosol-infected mice were tested for in vitro proliferation against heat-killed B. pertussis cells (106/ml), formaldehyde-treated pertussis sonic extract (5 pg/ml), FHA (1 p,g/ml), pertactin (5 ,ug/ml), and PT (0.2 p,g/ml) as previously described (32 lungs slowly declined, and bacteria were undetectable 35 days after challenge.
To study the possible contribution of T cells in the pulmonary clearance of a primary pertussis infection, we also examined the course of infection in T-cell-deficient nude (BALB/c nu/nu) mice. In contrast to the euthymic BALB/c mice, athymic BALB/c mice developed a persistent infection and failed to clear the bacteria (Fig. 1) . As in normal mice, the levels reached a peak on day 7, but the levels remained high for at least 42 days (the longest period of study).
Adoptive transfer of protective immunity into nude mice with B. pertussis-immune T cells. The mechanism of protective immunity to pertussis generated by natural infection was studied by adoptive transfer of spleen cell subpopulations from immune animals. Spleen cells derived from convalescent mice that had cleared primary respiratory infection after aerosol exposure 6 weeks earlier provided a source of immune cells and will be referred to as such hereafter.
Transfer of total immune BALB/c spleen cells into BALB/c athymic mice conferred on the nude mice the ability to reduce the detectable bacteria to fewer than 100 CFU per lung within 14 days after challenge (Fig. 2) seen in normal naive mice ( Fig. 1 and 3A (Fig. 3A) . However, removal of B cells also reduced the rate of clearance (Fig. 3A) . These findings confirm the protective role of immune T cells demonstrated in the nude mice ( Fig. 2) but also suggest that immune B cells contribute to protection, possibly through an amnestic antibody response after challenge.
Transfer of immune cells did not result in the same level of protection as that effected by the intact immune system; rechallenge of convalescent mice resulted in rapid bacterial clearance that was complete 7 days after challenge (Fig. 3A) . The results suggest that factors other than cells from a single lymphoid organ, such as circulating or mucosal antibodies, also contribute to the clearance of bacteria in immune animals.
The role of circulating antibody in protection against infection was assessed by passive transfer of serum from convalescent immune animals. In comparison with serum from control naive mice, immune serum injected intravenously before challenge reduced the viable B. pertussis counts in the lungs of recipient mice by approximately 1 log unit soon after challenge (Fig. 3B) .
MHC restriction of protective T cells. Since our cell purification techniques employed depletion rather than positive enrichment, it was important to rule out the possible contribution of non-MHC-restricted effector cells such as macrophages, NK cells, or TCR--y/8& T cells that may have been present in our T-cell preparations. The availability of B1O.AQR congenic mice compatible with CBA (H-2k) mice at the MHC class II loci enabled us to examine the MHC restriction of protection with CBA mice as recipients of purified T cells (Fig. 4) cells involved in protection against respiratory pertussis infection was examined by adoptive transfer of purified immune CD4+ or CD8+ T-cell subpopulations. The CD4+ and CD8+ T cells were purified from spleen cells by B-cell, macrophage, and CD8+ or CD4+ depletion, respectively, and FACScan analysis revealed that they were 75 to 80% pure with less than 2% contamination with the reciprocal subset and less than 5% B cells. A positive role for CD4+ was clearly demonstrated in the experiments shown in Fig.  5A . Transfer of immune CD4+ T cells followed by respiratory B. pernussis challenge resulted in complete bacterial clearance by day 20. In contrast, CD8+ T cells did not confer any protection; on days 14 and 21, the viable counts in the lung were 106 to 107, approximately 10-fold higher than those in the control group injected with nonimmune T cells from naive BALB/c mice (Fig. SB) . One of the animals injected with CD8+ cells in this experiment and two in a second experiment (data not shown) died 16 to 20 days after ch. lenge. Transfer of an equivalent number (107) of unseparated immune T cells reduced the bacterial load 100-fold by day 21 (Fig. 5B) . The less significant clearance seen with the T cells in this experiment compared with those shown in Fig.  3A and 4 may be accounted for by a reduction in the total numbers of cells transferred in this experiment (designed so that equal numbers of cells were injected into each mouse). Furthermore, the possible negative influence of the CD8+ T cells may also have contributed to reduced clearance with total T cells when compared with that seen in mice injected with the purified CD4+ T-cell population (Fig. SA) .
Further evidence for the protective role of antigen-specific CD4+ T cells was provided by the demonstration that a short-term T-cell line, BPF48, specific for FHA, also conferred a high level of immunity against aerosol challenge (Fig. SA) . The T-cell line was generated from the spleen cells of a convalescent mouse taken 8 weeks after respiratory VOL. 61, 1993 on August 14, 2017 by guest http://iai.asm.org/ Downloaded from infection by in vitro stimulation with FHA for 5 days followed by reculture in medium with feeder cells for 7 days. Phenotypic analysis of the line revealed that it included 65% CD4+, 12% CD8+, and 5% surface Ig+ cells. Although this and other B. pertussis-specific T-cell lines and clones have been maintained in culture for prolonged periods, a shortterm line was deliberately chosen for transfer to maintain a broader antigen specificity and to increase the possibility of retaining homing receptors. In comparison with a control CD4+ T-cell line specific for an unrelated poliovirus antigen, transfer of the FHA-specific T-cell line resulted in a substantial reduction in the lung counts 14 and 21 days after pertussis challenge.
Antibody responses after B. pertussis infection. Having established a role for T cells in the protective immune response to B. pertussis, we attempted to define the mechanism of T-cell-mediated clearance by examining antibody responses in mice after primary or secondary challenge and after CD4+ T-cell transfer. Circulating serum antibodies to PT, FHA, pertactin, or a B. pertussis sonic extract were almost undetectable by the ELISA up to 4 weeks after primary infection in normal BALB/c mice (Fig. 6A) . At 6 weeks, when the animal would have already cleared the infection (Fig. 1) , 6 U of serum antibodies to PT per ml were demonstrated; the amounts increased steadily thereafter (Fig. 6A) . A weak antibody response to FHA was detected at 6, 8, and 12 weeks postinfection, but levels of antibody to pertactin and a B. perussis sonic extract in serum remained below detectable levels up to 12 weeks after infection. The lack of a detectable IgG response to the B. pertussis sonic extract probably reflects the overall low levels of antipertussis antibody in convalescent-phase serum and the relatively small proportion of individual components (e.g., PT and FHA) in the sonic extract. IgM antibodies to B. pertussis were also undetectable in serum throughout the period of study (data not shown). By comparison, immunization with the whole-cell vaccine (two doses) induced approximately 100 U of IgG against FHA, PT, pertactin, and B. pertussis sonic extract per ml in serum (data not shown).
The generation of antibodies to pertussis in the lung was also examined at intervals after infection. Specific IgA antibody levels were found in lung homogenates (Table 1) and lung lavage samples, but IgA antibodies were undetectable in serum (data not shown). PT-specific IgA antibodies were present in the lungs 14 days after infection, but IgA antibodies to a B. pertussis sonic extract only reached detectable levels 2 weeks later (Table 1 ). In contrast, enhanced lung IgA antibodies were demonstrated against PT and a B. pertussis sonic extract 14 days after rechallenge of convalescent mice.
The serum of mice that had been challenged after transfer of murine CD4+ T cells was also examined for anti-B. pertussis antibodies. Twenty days after challenge, when the mice had cleared the infection, we failed to detect in serum any IgG, IgM, or IgA antibodies to a B. pertussis sonic extract, PT, FHA, or pertactin (Table 1 ; data not shown).
B. pertussis-specific T-cell responses in immune mice. In contrast to the low levels and late appearance of anti-B. pertussis antibodies, strong T-cell responses (detected by in vitro proliferation and lymphokine production) were consistently demonstrated 2, 4, 6, 8, and 12 weeks after primary infection (Fig. 6B) . The T cells generated by infection Weeks after Challenge or IL-4) that support the growth of the CTLL cell line ( Table  3 ). The addition of an MAb to IL-4, which completely inhibited the response of the CTLL line to IL-4, did not reduce the proliferation of the CTLL line in the presence of supernatants from the antigen-stimulated spleen cells, suggesting that the lymphokine detected was predominantly IL-2. We also failed to detect IL-4 with the immunoassay (Table 4) . However, significant levels of IFN-y were demonstrated in supernatants from immune spleen cells stimulated with B. pertussis antigen in vitro (Table 4) . Purified T cells or CD4+ T cells from spleens of immune mice also responded with IL-2 production (Table 5 ) and proliferation (data not shown) to a range of B. pertussis antigens. In contrast, CD8+ T cells failed to proliferate or secrete IL-2 in response to heat-killed B. pertussis, FHA, or Spleen + PT (0.2 jig/ml) 11.6 ± 1.7 14.4 ± 2. pertactin. infectious pathogens is well documented (23, 31, 35) . CD4+ T cells have been predominantly implicated in providing helper function for humoral immune response to extracellular pathogens (7, 18, 21, 35) , whereas CD8+ cytotoxic T lymphocytes (CTL) have been shown to be capable of controlling diseases resulting from infection with viruses (31, 57) and intracellular bacteria (23) and parasites (62) . However, CD4+ T cells can also mediate cellular immunity against intracellular pathogens through the lysis of infected cells (24, 37, 59) or by releasing cytokines that stimulate antimicrobial activity of neutrophils or macrophages (26, 50, 56) . Since until recently B. pertussis was considered to be a noninvasive bacterium, it has been generally assumed that protective immunity to this pathogen, like that to other extracellular pathogens, is exclusively mediated by antibodies (18) (19) (20) (21) 60) . Circumstantial evidence for the role of T cells in immunity to pertussis is provided by the suggestion of an in vivo intracellular state for B. pertussis, which would escape immune defenses mediated by humoral responses (8, 11, 16, 28, 48) . However, there has been little attempt to establish a direct role of T cells in protective immunity to pertussis.
In the present study we used the murine aerosol infection model to examine the mechanism of acquired resistance generated by respiratory infection. Although the intracerebral challenge model has been accepted as the laboratory correlate for vaccine-induced protection in humans and has been used extensively to study the role of antipertussis antibody in active and passive immunization experiments (43) , its relevance to studies of the mechanism of protective immunity is questionable. The lack of virulence of fresh clinical isolates of B. pertussis by this route and the possible differences in host bacterial interaction in the brain and respiratory tract are serious concerns (25, 38, 47) . Therefore, we use the nonlethal mouse aerosol infection model, in which many of the parameters of the infection are similar to those observed in children (41, 45, 55) . Our rationale for the study of donors that had had previous B. pertussis infection rather than immunization is based on the observation that the strongest and most persistent immunity in humans (17) and mice (3, 5) is generated by respiratory infection; therefore, our approach provides a sound basis for dissecting the protective immune response and for designing improved vaccination strategies. Natural immunity induced by infection may prevent respiratory colonization, whereas that generated by current pertussis vaccines may mainly protect against toxin-induced disease (17) . The The significant reduction in bacterial counts in lungs after transfer of a short-term FHA-specific T-cell line provides further evidence for the protective role of CD4+ T cells. The lymphokine secretion pattern of this T-cell line and those of the majority of T-cell clones generated from convalescent mice were characteristic of Thl cells (5) . Furthermore, in vitro antigen stimulation of spleen cells from convalescent mice resulted in production of IL-2 and IFN--y but no detectable IL-4. However, the detection of cytokines secreted by Th2 cells may require in vitro restimulation (7) . Indeed, we have found that a minority of B. pertussisspecific CD4+ T-cell clones generated from infected mice do produce IL-4 (5). Nevertheless, our results suggest that the predominant T cells induced by infection are Thl cells and are in agreement with the recent demonstration that B. pertussis-specific CD4+ T-cell clones from previously infected humans secrete IL-2 and IFN--y, but little or no IL-4, after in vitro antigen stimulation (40) .
The demonstration of clearance of B. pertussis from the lungs of mice in the absence of a significant serum antibody response during a primary infection and after transfer of CD4+ T cells is compatible with the role of Thl cells in classical cell-mediated immunity. Although we cannot rule out the possibility that the T cells provided helper activity for a mucosal IgA response in the lung, the synthesis of IgA appears to be primarily under the control of Th2 cells. has been shown to be involved in B-cell IgA isotype switch from IgM precursors, whereas IL-5 and IL-6 stimulate IgA synthesis by IgA-committed B cells (6, 14, 27) . However, IL-2 alone or in combination with IFN-,y or transforming growth factor 1 has also been implicated in stimulating IgA production by acting at the pre-or postswitch level (12, 14, 36) . Our findings of enhanced anti-B. pertussis IgA levels in the lungs after challenge of convalescent mice is suggestive of a role of mucosal antibodies in protective immunity to pertussis. The function of distinct T-cell subsets and their secreted cytokines in the regulation of this response remains to be established.
Alternatively, there are a number of possible mechanisms of non-antibody-mediated cellular immunity to pertussis. Thl cells have been shown to play a role in immunity to intracellular pathogens through their cytotoxic function against the infected cells (24, 59). Although B. pertussis has been considered to be a noninvasive pathogen and replicates on the surface of epithelial cells, recent evidence suggests that it can enter and survive within mammalian cells, including pulmonary macrophages. Furthermore, CD4+ T-cell clones derived from immune humans have been shown to display in vitro cytotoxic activity against B. pertussis-pulsed target cells (40) . Therefore, CD4+ CTL could, through the release of organisms for attack by other immune effector mechanisms, help to destroy this intracellular reservoir of bacteria and thereby limit the course of the infection. B.
pertussis-specific CD4+ T cells could also stimulate the antibacterial activity of phagocytic cells. The cytokines IFN--y and lymphotoxin, which are released by Thl cells, have been shown to mediate protection against other infectious diseases through the stimulation, recruitment, and activation of macrophages and neutrophils (26, 50) . However, cellular responses mediated by Thl cells have been largely associated with protection against intracellular bacteria (24, 37) . It remains to be defined whether the Thl-like responses demonstrated in the present study are exclusively directed against the putative intracellular phase of pertussis or also involved in clearance of the predominantly extracellular organisms.
Our findings do not obviate an antibody-mediated mechanism of immunity to pertussis generated by immunization. However, in the present murine model of natural immunity the capacity to generate a rapid and consistent CD4+ T-cell response appears to be a major factor in the development of host resistance to a B. pertussis respiratory infection. Since the nonlethal respiratory infection of adult mice with B. pertussis is a model for colonization and not for disease, it cannot be concluded that the same immune effector mechanisms operate in protection against the human disease. Nevertheless, when taken together with the demonstration of B. pertussis-specific T-cell induction and lack of serological correlates of protection in humans (2, 15, 40) , these findings suggest that cell-mediated immunity also plays a role in the prevention or control of pertussis in humans. Therefore, future development and evaluation of pertussis vaccines should be orientated toward stimulation and testing of cellular as well as humoral immunity.
